GH1 and hyperprolactinemia: The limitation of the above inclusion criteria, as noted by Wildemberg et al., is that some somatotroph tumors with intratumoral PRL expression in up to 5% of cells have elevated PRL levels due to the stalk effect, and some patients with GH/PRL positive tumors may not present with hyperprolactinemia (35).